Overview of Upcoming Investor Conferences
Prenetics Global Limited (NASDAQ: PRE), a prominent health sciences company, is preparing to engage investors through its participation in two important upcoming investor conferences. These events are designed to showcase the company's continued commitment to innovation and excellence in health care solutions.
iAccess Alpha Virtual Best Ideas Winter Conference 2024
The first of these conferences is the iAccess Alpha Virtual Best Ideas Winter Conference 2024, taking place from December 10 to December 11, 2024. This virtual format allows for broad participation from investors and industry stakeholders.
Key Presentation Details
During this conference, Danny Yeung, the Chief Executive Officer of Prenetics, will lead a presentation on December 10, 2024, at 10:00 AM ET. He will be accompanied by Stephen Lo, Chief Financial Officer, and David Vanderveen, President of Prenetics Americas, who will participate in one-on-one meetings with investors on the following day.
13th Annual ROTH Deer Valley Event
The second major event in which Prenetics will participate is the 13th Annual ROTH Deer Valley Event, scheduled for December 11 through December 13, 2024, in Park City, UT. This event also highlights the opportunities for direct engagement with the Prenetics management team.
Individual Meetings with Investors
At this conference, David Vanderveen will spearhead a series of one-on-one meetings aimed at fostering deeper investor relationships. Mr. Vanderveen brings a wealth of experience with over 30 years in beverage, nutrition, and technology sectors, demonstrating strong leadership in transformative roles at various reputable companies.
Understanding Prenetics' Commitment to Health
Prenetics is at the forefront of advancing health science through innovative solutions that merge consumer needs and clinical effectiveness. With their consumer initiative driven by IM8, a health and wellness brand, and Europa, a leading sports distribution company, Prenetics aims to enhance the quality of life for everyday consumers.
Innovations in Clinical Health
The clinical segment of Prenetics, anchored by Insighta, focuses on multi-cancer early detection technologies, backed by a robust $200 million investment. Moreover, ACT Genomics has received FDA clearance for its comprehensive genomic profiling for solid tumors, promoting a new frontier in personalized medicine. CircleDNA also contributes by providing in-depth genetic testing powered by next-generation sequencing.
Connecting with Prenetics' Management
For those interested in learning more or wanting to arrange a meeting with the Prenetics management team during these conferences, they are encouraged to reach out through the company's investor relations contact. Prenetics is keen on creating meaningful dialogues with their investors, reinforcing their strategic vision and alignment in the health sciences domain.
Frequently Asked Questions
What is the reason for Prenetics' participation in these conferences?
Prenetics aims to enhance investor engagement and showcase its innovative health solutions through presentations and one-on-one meetings.
Who will be presenting at the iAccess Alpha Conference?
CEO Danny Yeung will present, joined by CFO Stephen Lo and President David Vanderveen for investor meetings.
When is the ROTH Deer Valley Event scheduled?
The ROTH Deer Valley Event will take place from December 11 to 13, 2024.
How can investors schedule meetings with Prenetics’ management?
Investors can contact Prenetics' investor relations for meeting arrangements during the conferences.
What innovations is Prenetics focused on in health sciences?
Prenetics is focused on early cancer detection technologies, genomic profiling, and comprehensive DNA tests to advance healthcare solutions.
